123-I ioflupane (Datscan®) presynaptic nigrostriatal imaging in patients with movement disorders

123-I ioflupane (Datscan®) presynaptic nigrostriatal imaging in patients with movement disorders

123-I Ioflupane (Datscan®) presynaptic imaging has been shown to have a significant utility in the assessment of patients with movement disorders 123-I Ioflupane SPECT is able to distinguish between Parkinson’s disease (PD) and other forms of parkinsonism without degeneration of the nigrostriatal pathway, including a common movement disorder such as essential tremor, and to assess disease progression in PD and other neurodegenerative disorders involving the substantia nigra.

Saved in:
Bibliographic Details
Main Authors: Soriano Castrejón,Angel, García Vicente,Ana María, Cortés Romera,Montserrat, Cano,Julia Vaamonde, Marina,Sonia Rodado, Poblete García,Victor Manuel, Ruiz Solís,Sebastián, Talavera Rubio,María del Prado
Format: Digital revista
Language:English
Published: Instituto de Tecnologia do Paraná - Tecpar 2005
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132005000700017
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132005000700017

Similar Items